Akin Advised RP Management on Its $1.1 Billion Sale to Royal Pharma
January 11, 2025
January 11, 2025
WASHINGTON, Jan. 11 -- Akin Gump, a law firm, issued the following news release:
(New York and Los Angeles) - Akin advised RP Management, LLC in connection with its sale to Royal Pharma plc. for approximately $1.1 billion in cash, stock and assumed debt.
The deal is expected to close in the second half of 2025, subject to shareholder approval and other customary closing conditions.
The Akin team was led by partners Stuart Leblang, David Antheil and Eric We . . .
(New York and Los Angeles) - Akin advised RP Management, LLC in connection with its sale to Royal Pharma plc. for approximately $1.1 billion in cash, stock and assumed debt.
The deal is expected to close in the second half of 2025, subject to shareholder approval and other customary closing conditions.
The Akin team was led by partners Stuart Leblang, David Antheil and Eric We . . .